Abstract
A cluster-randomized controlled trial (RCT) was conducted to evaluate to the effectiveness of reducing mortality of upper gastrointestinal cancer (UGC) and feasibility of screening through a questionnaire combined with endoscopy in non-high-incidence urban areas in China. The trial design, recruitment performance, and preliminary results from baseline endoscopy are reported. Seventy-five communities in two urban cities with a non-high-incidence of UGC were randomized to a screening endoscopy arm (n = 38) or a control arm (n = 37). In the screening arm, individuals at high risk of UGC underwent endoscopic screening. The primary outcome was the UGC mortality, and secondary outcomes included the UGC detection rate, incidence rate, survival rate, and clinical stage at the time of diagnosis. A total of 10,416 and 9,565 individuals were recruited into the screening and control arms, respectively. The participation rate was 74.3%. In the screening arm, 5,242 individuals (50.3%) were estimated to be high-risk. Among them, 2,388 (45.6%) underwent endoscopic screening. Age and household income were associated with undergoing endoscopy. Three early esophageal cancer (0.13%), one gastric cancer (0.04%), 29 precancerous esophageal lesions (1.21%), and 53 precancerous gastric lesions (2.22%) were detected. Age, sex, a family history of cancer, intake of meat-egg-milk frequently, superficial gastritis, and clinical symptoms of gastric cancer were associated with the presence of precancerous lesions. The detection rate was low using endoscopic screening in non-high-incidence area given the relatively low compliance rate. These findings provide a reference for designing effective community-based UGC screening strategies in non-high-incidence urban areas.
Highlights
Upper gastrointestinal cancer (UGC) containing esophageal cancer and gastric cancer is one of the most common cancers worldwide, with about 50% new cases and deaths occurring in China [1, 2]
19,981 individuals were recruited with a participation rate of 74.3%, including 10,416 in the screening arm and 9,565 in the control arm
We designed a questionnaire to initially evaluate participants to identify those at high risk on UGC
Summary
Upper gastrointestinal cancer (UGC) containing esophageal cancer and gastric cancer is one of the most common cancers worldwide, with about 50% new cases and deaths occurring in China [1, 2]. In China, UGC ranks second both in terms of cancer incidence and cancer-related mortality. The prognosis of UGC is closely related to the time of diagnosis and treatment. The 5-year survival rate of patients diagnosed at an early stage of UGC is much higher than in those diagnosed at an advanced stage [3]. In China, the 5-year survival rate of UGC is relatively low at below 36% [4].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.